Does hsa-miR-223-3p from platelet-derived extracellular vesicles regulate tissue factor expression in monocytic...

Area of Science:

• Biochemistry and Molecular Biology
• Hematology
• Cell Biology

Background:

• Platelet-derived extracellular vesicles (pdEVs) are rich in microRNAs, including hsa-miR-223-3p.
• Endogenous hsa-miR-223-3p inhibits tissue factor (TF) expression in endothelial cells, a key regulator of coagulation.
• The role of hsa-miR-223-3p in regulating TF in monocytes is not well understood.

Purpose of the Study:

• To investigate whether hsa-miR-223-3p delivered via pdEVs influences TF expression in monocytes.
• To determine the specific role of hsa-miR-223-3p in modulating monocyte TF expression and procoagulant activity.

Main Methods:

• THP-1 cells, differentiated into monocytes, were transfected with hsa-miR-223-3p mimic or control microRNA.
• Cells were also incubated with pdEVs derived from activated platelets.
• TF protein levels, TF expression, and procoagulant activity were assessed using western blotting, flow cytometry, and factor Xa generation assays.

Main Results:

• Transfection with hsa-miR-223-3p mimic significantly reduced TF protein, TF expression, and procoagulant activity in monocytes.
• This reduction was reversible with the co-transfection of an hsa-miR-223-3p inhibitor (AntagomiR-223).
• Incubation with pdEVs also decreased TF expression, but this effect was not reversed by AntagomiR-223, indicating other pdEV components contribute to TF regulation.

Conclusions:

• Monocyte TF expression is downregulated by hsa-miR-223-3p.
• While pdEVs can transfer hsa-miR-223-3p to monocytes, the resulting TF downregulation is not solely dependent on this microRNA.
• Other components within pdEVs may play a significant role in regulating monocyte TF expression and coagulation.